Related Experiment Video
Updated: Apr 30, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
The case for angioplasty in patients with symptomatic intracranial atherosclerosis
Ryan A McTaggart1, Michael P Marks2
1Department of Radiology, Cleveland Clinic Florida , Weston, FL , USA ; Department of Neurosurgery, Cleveland Clinic Florida , Weston, FL , USA ; Cerebrovascular Center, Neurological Institute, Cleveland Clinic , Cleveland OH , USA.
Insights
Intracranial atherosclerotic disease (ICAD) causes many strokes globally. Stenting plus aggressive medical management was found inferior to aggressive medical management alone for ICAD, renewing interest in angioplasty.
Area of Science:
- Neurology
- Vascular Medicine
- Interventional Cardiology
Background:
- Intracranial atherosclerotic disease (ICAD) is a leading cause of stroke worldwide.
- Despite medical therapy, ICAD carries significant morbidity.
- The SAMMPRIS trial demonstrated stenting's inferiority to aggressive medical management for ICAD.
Purpose of the Study:
- To review the natural history of intracranial atherosclerotic disease.
- To discuss the potential role of endovascular treatments for symptomatic ICAD.
- To explore primary intracranial angioplasty for select ICAD patients.
Main Methods:
- Review of natural history data for ICAD.
- Analysis of recent clinical trial outcomes (SAMMPRIS).
- Discussion of endovascular treatment strategies for ICAD.
Main Results:
- Aggressive medical management alone proved superior to stenting plus aggressive medical management in the SAMMPRIS trial.
- These findings have prompted re-evaluation of endovascular options for ICAD.
- Angioplasty alone is being reconsidered for symptomatic ICAD.
Conclusions:
- Primary intracranial angioplasty may offer a future treatment for carefully selected ICAD patients.
- Further research is needed to define the optimal role of angioplasty in ICAD management.
- Endovascular strategies for ICAD require careful consideration post-SAMMPRIS.
Abstract:
Intracranial atherosclerotic disease (ICAD) is likely the most common cause of stroke worldwide and remains highly morbid even with highly monitored medical therapy. Recent results of the SAMMPRIS trial, which randomized patients to stenting plus aggressive medical management versus aggressive medical management alone have shown that additional treatment of intracranial atherosclerotic lesions with the Wingspan stent is inferior to aggressive medical management alone. In light of these results, there has been renewed interest in angioplasty alone to treat symptomatic ICAD. This article will briefly review the natural history of ICAD and discuss the possible future for endovascular treatment of ICAD with primary intracranial angioplasty in appropriately selected patients.
More Related Videos
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Angina IV: Management
Aneurysm III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Artery Disease III: Interprofessional Care

